Aspect Medical Systems 10-Q 2007
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
(Amendment No. 1)
For the quarterly period ended June 30, 2007
For the transition period from to
Commission file number: 0-24663
Aspect Medical Systems, Inc.
(Exact name of Registrant as Specified in Its Charter)
Registrants telephone number, including area code
Securities registered pursuant to Section 12(b) of the Act: None
Securities registered Pursuant to Section 12(g) of the Act:
Common Stock, $0.01 Par Value
(Title Of Class)
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
YES x NO o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer or a non-accelerated filer. See definition of accelerated filer and large accelerated filer in Rule 12b-2 of the Exchange Act.
Large accelerated filer o Accelerated filer x Non-accelerated filer o
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
YES o NO x
The Registrant had 16,994,654 shares of Common Stock, $0.01 par value per share, outstanding as of August 1, 2007.
This Amendment No. 1 to Quarterly Report on Form 10-Q/A (Amendment No. 1) is being filed to correct the number of shares of the registrants common stock outstanding as of August 1, 2007 included on the cover page of the registrants Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2007, filed with the Securities and Exchange Commission on August 9, 2007 (Original Form 10-Q).
Pursuant to Rule 12b-15 promulgated under the Securities Exchange Act of 1934, the registrant is filing updated exhibits 31.1, 31.2, 32.1 and 32.2. in connection with filing Amendment No. 1.
Except for the matters described above, Amendment No. 1 does not modify or update disclosure in, or exhibits to, the Original Form 10-Q. Furthermore, except for the matters described above, Amendment No. 1 does not change any previously reported financial results, nor does it reflect events occurring after the date of the Original Form 10-Q. Any information not affected by Amendment No. 1 is unchanged and reflects the disclosures made at the time the Original Form 10-Q was filed.
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.